1,586
Views
1
CrossRef citations to date
0
Altmetric
Clinical Study

Combination of the gut microbiota and clinical indicators as a potential index for differentiating idiopathic membranous nephropathy and minimal change disease

, , , , , , , , & show all
Article: 2209392 | Received 09 Jan 2023, Accepted 27 Apr 2023, Published online: 18 May 2023

References

  • Orth SR, Ritz E. The nephrotic syndrome. N Engl J Med. 1998;338(17):1–14.
  • Ng JK-C, Ma TK-W, Lai FM-M, et al. Causes of nephrotic syndrome and nephrotic-range proteinuria are different in adult Chinese patients: a single centre study over 33 years. Nephrology. 2018;23(6):565–572.
  • Floege J, Amann K. Primary glomerulonephritides. Lancet. 2016;387(10032):2036–2048.
  • Beck LH, Bonegio RGB, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361(1):11–21.
  • Rovin BH, Adler SG, Barratt J, et al. Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases. Kidney Int. 2021;100(4):753–779.
  • Dai P, Campbell D, Culican S, et al. Validation of phospholipase a receptor direct immunofluorescence staining in the diagnosis of primary membranous glomerulonephritis. Pathology. 2020;52(5):546–551.
  • Larsen CP, Messias NC, Silva FG, et al. Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies. Mod Pathol. 2013;26(5):709–715.
  • Zhang J, Luo D, Lin Z, et al. Dysbiosis of gut microbiota in adult idiopathic membranous nephropathy with nephrotic syndrome. Microb Pathog. 2020;147:104359.
  • Tsuji S, Kaneko K. The long and winding road to the etiology of idiopathic nephrotic syndrome in children: focusing on abnormalities in the gut microbiota. Pediatr Int. 2021;63(9):1011–1019.
  • Godon JJ, Zumstein E, Dabert P, et al. Molecular microbial diversity of an anaerobic digestor as determined by small-subunit rDNA sequence analysis. Appl Environ Microbiol. 1997;63(7):2802–2813.
  • Segata N, Izard J, Waldron L, et al. Metagenomic biomarker discovery and explanation. Genome Biol. 2011;12(6):R60.
  • Jiang S, Fang J, Yu T, et al. Novel model predicts diabetic nephropathy in type 2 diabetes. Am J Nephrol. 2020;51(2):130–138.
  • Cheng Y, Shang J, Liu D, et al. Development and validation of a predictive model for the progression of diabetic kidney disease to kidney failure. Ren Fail. 2020;42(1):550–559.
  • Wang T, Yu W, Wu F, et al. Construction of a nomogram discriminating malignancy-associated membranous nephropathy from idiopathic membranous nephropathy: a retrospective study. Front Oncol. 2022;12:914092.
  • Ren Z, Fan Y, Li A, et al. Alterations of the human gut microbiome in chronic kidney disease. Adv Sci. 2020;7(20):2001936.
  • Zhao X, Zhang Y, Guo R, et al. The alteration in composition and function of gut microbiome in patients with type 2 diabetes. J Diabetes Res. 2020;2020:8842651.
  • Sheng C, Yang K, He B, et al. Combination of gut microbiota and plasma amyloid-β as a potential index for identifying preclinical Alzheimer’s disease: a cross-sectional analysis from the SILCODE study. Alzheimers Res Ther. 2022;14(1):35.
  • Ke S, Pollock NR, Wang X-W, et al. Integrating gut microbiome and host immune markers to understand the pathogenesis of infection. Gut Microbes. 2021;13(1):1–18.
  • Gupta VK, Cunningham KY, Hur B, et al. Gut microbial determinants of clinically important improvement in patients with rheumatoid arthritis. Genome Med. 2021;13(1):149.
  • Wu F, Zhang Y, Cui W, et al. Development and validation of a discrimination model between primary PLA2R-negative membranous nephropathy and minimal change disease confirmed by renal biopsy. Sci Rep. 2021;11(1):18064.
  • Lu Q, Stappenbeck TS. Local barriers configure systemic communications between the host and microbiota. Science. 2022;376(6596):950–955.
  • Miyauchi E, Shimokawa C, Steimle A, et al. The impact of the gut microbiome on extra-intestinal autoimmune diseases. Nat Rev Immunol. 2023;23(1):9–23.
  • Dong R, Bai M, Zhao J, et al. A comparative study of the gut microbiota associated with immunoglobulin a nephropathy and membranous nephropathy. Front Cell Infect Microbiol. 2020;10:557368.
  • Li M, Wei L, Sun J, et al. Association of gut microbiota with idiopathic membranous nephropathy. BMC Nephrol. 2022;23(1):164.
  • Shang J, Zhang Y, Guo R, et al. Gut microbiome analysis can be used as a noninvasive diagnostic tool and plays an essential role in the onset of membranous nephropathy. Adv Sci. 2022;9(28):e2201581.
  • Zhao J, Bai M, Ning X, et al. Expansion of in gut is associated with the onset and response to immunosuppressive therapy of IgA nephropathy. J Am Soc Nephrol. 2022;33(12):2276–2292.
  • Petrzik K, Brázdová S, Krawczyk K. Novel viruses that lyse plant and human strains of Kosakonia cowanii. Viruses. 2021;13(8):1418.
  • Berinson B, Bellon E, Christner M, et al. Identification of Kosakonia cowanii as a rare cause of acute cholecystitis: case report and review of the literature. BMC Infect Dis. 2020;20(1):366.
  • Chen M, Fan H-N, Chen X-Y, et al. Alterations in the saliva microbiome in patients with gastritis and small bowel inflammation. Microb Pathog. 2022;165:105491.
  • Wang Z, Koonen D, Hofker M, et al. Gut microbiome and lipid metabolism: from associations to mechanisms. Curr Opin Lipidol. 2016;27(3):216–224.
  • Xu X, Wang G, Chen N, et al. Long-Term exposure to air pollution and increased risk of membranous nephropathy in China. J Am Soc Nephrol. 2016;27(12):3739–3746.